Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED database
Open Access
- 1 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 6 (1) , vdae179
Abstract
Ependymomas of the spinal cord are rare among children and adolescents, and the individual risk of disease progression is difficult to predict. This study aims at evaluating the prognostic impact of molecular typing of pediatric spinal cord ependymomas. Eighty-three patients with spinal ependymomas ≤22 years registered in the HIT-MED database between 1992 and 2022 were included. Forty-seven tumors were analyzed by DNA methylation array profiling. In six cases, HOXB13 and MYCN proteins were detected as surrogate markers for specific methylation classes. Ten patients had NF2-related schwannomatosis. With a median follow-up time of 4.9 years (y), 5y- and 10y-overall survival (OS) were 100% and 86%, while 5y- and 10y-progression-free survival (PFS) were 65% and 54%. Myxopapillary ependymoma (SP-MPE, n=32, 63%) was the most common molecular type followed by spinal ependymoma (SP-EPN, n=17, 33%) and MYCN-amplified ependymoma (n=2, 4%). One case could not be molecularly classified, and one was reclassified as anaplastic pilocytic astrocytoma. 5y-PFS did not significantly differ between SP-MPE and SP-EPN (65% versus 78%, p=0.64). MYCN-amplification was associated with early relapses (MYCN-amplified ependymomas. Further insights into the molecular heterogeneity of spinal ependymomas are needed for future clinical decision-making.Keywords
Funding Information
- Steirische Kinderkrebshilfe
This publication has 25 references indexed in Scilit:
- Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsCancer Cell, 2015
- Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer NetworkNeuro-Oncology, 2014
- Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus childrenJournal of Neurosurgery: Spine, 2013
- Management of Pediatric Myxopapillary Ependymoma: The Role of Adjuvant RadiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Spinal cord ependymomas in children and adolescentsChild's Nervous System, 2012
- Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT databaseJournal of neurosurgery. Pediatrics, 2010
- Neurofibromatosis type 2The Lancet, 2009
- Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results studyJournal of Neurosurgery, 2009
- Resection of myxopapillary ependymomas in childrenJournal of neurosurgery. Pediatrics, 2007
- Intramedullary Spinal Cord Ependymomas in Children: Treatment, Results and Follow-UpPediatric Neurosurgery, 1998